(Q43262235)
Statements
Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL) (English)
G Cervetti
E Sordi
G Buda
E Orciuolo
N Cecconi
scientific article published on 13 October 2009